FFA
PACB icon

Farther Finance Advisors’s Pacific Biosciences PACB Stock Holding History

Farther Finance Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$461 Sell
274
-1,282
-82% -$1.86K ﹤0.01% 5551
2026
Q1 		$2.1K Buy
1,556
+1,047
+206% +$1.87K ﹤0.01% 4885
2025
Q4 		$952 Buy
509
+391
+331% +$751 ﹤0.01% 4924
2025
Q3 		$151 Hold
118
– – ﹤0.01% 4776
2025
Q2 		$146 Sell
118
-83
-41% -$96 ﹤0.01% 4256
2025
Q1 		$227 Hold
201
– – ﹤0.01% 3928
2024
Q4 		$368 Sell
201
-15
-7% -$29 ﹤0.01% 3506
2024
Q3 		$367 Sell
216
-5
-2% -$8 ﹤0.01% 3495
2024
Q2 		$265 Buy
221
+63
+40% +$127 ﹤0.01% 3432
2024
Q1 		$577 Buy
158
+46
+41% +$269 ﹤0.01% 2972
2023
Q4 		$1.1K Sell
112
-764
-87% -$6.25K ﹤0.01% 2686
2023
Q3 		$7.32K Hold
876
– – ﹤0.01% 1393
2023
Q2 		$11.7K Sell
876
-1,076
-55% -$13.1K ﹤0.01% 1147
2023
Q1 		$22.6K Buy
+1,952
New +$19.4K 0.01% 859

Other funds holding PACB

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
KCPG
Kavar Capital Partners Group Leawood, Kansas $812M AUM 29.76% 1-Year Est. Return
APG
Abacus Planning Group Columbia, South Carolina $809M AUM 21.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
BCA
Bay Colony Advisors Concord, Massachusetts $903M AUM 33.67% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Farther Finance Advisors's PACB Position: Q2 2026 in Review

Farther Finance Advisors reduced its Pacific Biosciences (PACB) stake by 82% in Q2 2026, selling an estimated $1.86K and leaving 274 shares worth $461. The position accounts for ﹤0.01% of the portfolio, ranked #5551.

Farther Finance Advisors first reported a position in PACB in Q1 2023 and has held it in 14 quarters since. The position peaked at $22.6K in Q1 2023. 19 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Farther Finance Advisors held 274 shares of Pacific Biosciences worth $461 as of Q2 2026.
  • Farther Finance Advisors sold 1,282 Pacific Biosciences shares in Q2 2026, an estimated $1.86K.
  • Pacific Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5551 holding.
  • Farther Finance Advisors first reported a position in Pacific Biosciences in Q1 2023 and has held it in 14 quarters since.
  • Farther Finance Advisors's Pacific Biosciences position peaked at $22.6K in Q1 2023.
  • 19 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.